NSTEMI Risk Prediction with the Combination of the Biomarkers Epicardial Adipose Tissue and Soluble Suppression of Tumorigenicity 2

10 March 2025 : Clinical Research

Jiayu Yin^1ACEFG, Bowen Qiu^2BCEF, Tingting Li^1CE, Yifei Tao^3ADE*, Xiaosong Gu^1AG

DOI: 10.12659/MSM.947019

Med Sci Monit 2025; 31:e947019

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 2 Receiver operating characteristic curve for the prediction of major adverse cardiac events.

Parameter	AUC	95% CI	Cutoff value	Sensitivity (%)	Specificity (%)
sST2, ng/mL	0.720	0.657–0.784	53.35	0.712	0.630
EAT index (mL/m)	0.705	0.638–0.773	44.80	0.763	0.649
sST2+EAT index	0.752	0.684–0.821	–	0.746	0.758
sST2 – soluble suppression of tumorigenicity 2; EAT – epicardial adipose tissue; AUC – area under the curve; CI – confidence interval.

Back to the Article